Laxxon Medical to Participate in the Jefferies Global Healthcare Conference
October 20, 2026 · 4:01 PM · NEW YORK
Laxxon Medical Corp. (“Laxxon Medical” or the “Company”), a pharmaceutical technology company developing advanced drug delivery solutions through its proprietary SPID® (Screen Printed Innovative Drugs) technology, today announced that members of its senior management team will hold one-on-one investor meetings at the Jefferies Global Healthcare Conference, taking place November 16–19, 2026, in London, United Kingdom. During one-on-one meetings at the conference, manag...
- PublishedOctober 20, 2026 · 4:01 PM
- LocationNEW YORK
- IndustryScience
- LanguageEN
Published by Business Wire. Read the original announcement for the full release.
Read the full announcement →